Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Active ingredients: flecainide
What it is used for
Supraventricular arrhythmias, due to pre-excitation syndromes (e.g Wolff-Parkinson-White and Lown-Ganong-Levine syndromes) or to dual atrioventricular nodal pathways in patients with disabling symptoms; paroxysmal atrial flutter/fibrillation (PAF) associated with disabling symptoms. Although flecainide acetate may be effective in supraventricular arrhythmias in patients with structural heart disease, its use has been associated with life-threatening and occasionally fatal ventricular arrhythmias. In these patients, particularly in the presence of impaired left ventricular function, Flecatab should be used with extreme caution, preferably after other antiarrhythmic drugs have been tried or considered inappropriate. Use of flecainide acetate in chronic atrial fibrillation has not been adequately studied and is not recommended. Life-threatening ventricular arrhythmias not controlled by other drugs. An intravenous form of flecainide acetate is indicated when rapid control or short-term prophylaxis of the above arrhythmias is the main clinical requirement. All use of the injection should be in hospitals only. Flecatab is used for continuous maintenance of normal rhythm following initial oral or intravenous therapy or conversion by other means. See Warnings and Precautions.
How to take it
The way to take this medicine is: Oral. This medicine is taken by mouth.
- Store below 30 degrees Celsius
- Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
8.5mm normal convex white tablet, debossed FC/100 on one side, G on the reverse.
Images are the copyright of the Pharmacy Guild of Australia
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on June 1, 2021. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy?
For the active ingredient flecainide
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Consumer Medicines Information (CMI)
For side effects, taking other medicines and more
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems